Free Newsletter
| Get the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Sign up for free today! |
SPOTLIGHT: Chinese pharma recalls counterfeit drug
After discovering a syndicate counterfeiting its products, Chinese drug maker Holley-Cotec Pharmaceuticals is recalling anti-malarials supplied to Kenya. Twenty thousand doses of Duo-cotecxin, a type of artemisinin drug recommended by the World Health Organization for use against malaria, are involved in the recall. The company analyzed the fake meds and found they had very low levels of active ingredients. Kenyan officials said this is the first case of a counterfeit artemisinin drug, but fake anti-malarials are becoming a worldwide problem and could spur drug resistance in the germ. Holley-Cotec says it intends to use new tamper-proof technology on the replacement doses it supplies. Report
Be the first to comment
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
- Forecast Model: Antidyslipidemics - Genericization and negative trial data drive market shrinkage


